Evidence map›Paper›PMID 40748244›Full record

ArticleHuman molecular genetics2025

Bidirectional role of Costameres in the pathophysiology of mdx skeletal muscles.

Glen B Banks, Darren R Bisset, Jeffrey S Chamberlain

Abstract read
In one paragraph

Article in Human molecular genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Glen B BanksDepartment of Neurology, 1959 NE Pacific St, Seattle, WA 98195, United States.ORCID 0009-0008-0482-0678
Darren R BissetDepartment of Neurology, 1959 NE Pacific St, Seattle, WA 98195, United States.
Jeffrey S ChamberlainDepartment of Neurology, 1959 NE Pacific St, Seattle, WA 98195, United States.

Funding

Vector and Transgenic Mouse CoreP30DK017047 · NIDDK · UNIVERSITY OF WASHINGTON · PI Sakeneh Zraika · 1986 to 2026
$41.4M
DYSTROPHIN REPLACEMENT IN MDX MICER01AR040864 · NIAMS · UNIVERSITY OF WASHINGTON · PI JEFFREY S CHAMBERLAIN · 1991 to 2026
$8.8M
AHAMDANIDDK NIH HHS P30 DK017047NIH HHS R01AR040864
6 · The paper itself

Abstract

Skeletal muscles in Duchenne Muscular Dystrophy (DMD) are most susceptible to injury at a point in maturation when dystrophin is absent and utrophin dissipates from the membrane. The lack of the dystrophin glycoprotein complex (DGC) leaves a residual costameric scaffold that structurally connects the peripheral sarcomeres to the sarcolemma. However, the residual costameres are weak and transmit less lateral force making it unclear how they contribute to the pathophysiology of DMD. Here we found that costameres were near absent in mature mdx4cv:desmin double knockout (dko) fast 2b myofibers where the compensating utrophin protein is not upregulated at costameres. The lack of costameres decoupled sarcomere strain injury from tearing the membrane leading to isolated necrotic myofibers. Despite a 30% reduction in the proportion of myofibers with centrally located nuclei (a marker of degenerating/regenerating myofibers), the fast 2b dko muscles were atrophic and profoundly weakened by the sarcomere strain injury. Thus, our data is consistent with the DGC protecting the membrane and peripheral sarcomeres from the bidirectional forces that propagate through the desmin-fortified costameres.

Indexed as

CostameresMuscle, SkeletalMuscular Dystrophy, DuchenneAnimalsDesminDystrophinHumansMiceMice, Inbred mdxMice, KnockoutMuscle Fibers, SkeletalSarcolemmaSarcomeresUtrophinDesminDystrophinUtrophincostameredesminDuchennedystrophinlateral force transmissionskeletal muscle

Identifiers

PMID40748244
PMCPMC12498281

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.